Cargando…
Approaches to Improve Chemically Defined Synthetic Peptide Vaccines
Progress made in peptide-based vaccinations to induce T-cell-dependent immune responses against cancer has invigorated the search for optimal vaccine modalities. Design of new vaccine strategies intrinsically depends on the knowledge of antigen handling and optimal epitope presentation in both major...
Autores principales: | Hos, Brett J., Tondini, Elena, van Kasteren, Sander I., Ossendorp, Ferry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932164/ https://www.ncbi.nlm.nih.gov/pubmed/29755468 http://dx.doi.org/10.3389/fimmu.2018.00884 |
Ejemplares similares
-
Lipid A analog CRX-527 conjugated to synthetic peptides enhances vaccination efficacy and tumor control
por: Tondini, Elena, et al.
Publicado: (2022) -
Self-Adjuvanting
Cancer Vaccines from Conjugation-Ready Lipid A Analogues and Synthetic
Long Peptides
por: Reintjens, Niels R. M., et al.
Publicado: (2020) -
Improving the immunomodulatory function of mesenchymal stem cells by defined chemical approach
por: Cheng, Jintao, et al.
Publicado: (2022) -
MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression
por: Schrörs, Barbara, et al.
Publicado: (2023) -
A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control
por: Tondini, Elena, et al.
Publicado: (2019)